ClinicalTrials.gg
Drug

Cabazitaxel clinical trials

Also written Jevtana, XRP6258 and RPR-116258A.

studies test it
89
open now
6
in phase 3
11
first study started
1999

How each study uses cabazitaxel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the cabazitaxel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Jun 2010 · JEVTANA KIT · NDA 201023 (FDA, Drugs@FDA)
European Union
17 Mar 2011 · Jevtana · EMEA/H/C/002018 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Cabazitaxel
58
Cabazitaxel (XRP6258)
11
Taxoid XRP6258
6
cabazitaxel XRP6258
4
Jevtana, XRP6258, RPR116258A
2

Brand

Jevtana
47

Development codes

XRP6258
14
RPR-116258A
6
RPR116258
1

Studies by the year they started

88 studies that test it; most in 2012 (18)

Studies that test cabazitaxel, by start year
YearStudies
19991
20071
20092
20103
20119
201218
201314
20149
20157
20162
20179
20183
20192
20212
20221
20231
20241
20253

By phase

A phase 1/2 study counts in both.

Phase 1
21
Phase 2
67
Phase 3
11
Phase 4
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 21 · Other 68

Sanofi (19) · M.D. Anderson Cancer Center (4) · University Hospitals Bristol and Weston NHS Foundation Trust (3) · UNICANCER (2) · Gustave Roussy, Cancer Campus, Grand Paris (2) · Sidney Kimmel Cancer Center at Thomas Jefferson University (2) · Vejle Hospital (2) · Hellenic Cooperative Oncology Group (2)

Often tested with

Tested in the same studies.

Carboplatin (8) · Prednisone (8) · Abiraterone (6) · Enzalutamide (5) · Abiraterone Acetate (4) · Lutetium (¹⁷⁷Lu) vipivotide tetraxetan (3) · Docetaxel (3) · Nivolumab (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 4 phase 3 studies under way

Cabazitaxel is the comparator. A study of two new drugs counts under both.

  • 2Xaluritamig · Amgen · next primary completion Jan 2029
  • 2Darolutamide · ECOG-ACRIN Cancer Research Group, Karolinska Institutet · next primary completion Dec 2026
  • 1Enzalutamide · Karolinska Institutet · next primary completion Dec 2026
  • 1Abiraterone · Karolinska Institutet · next primary completion Dec 2026
  • 1Carboplatin · Karolinska Institutet · next primary completion Dec 2026
  • 1Docetaxel · Karolinska Institutet · next primary completion Dec 2026
  • 1Niraparib · Karolinska Institutet · next primary completion Dec 2026
  • 1Abiraterone Acetate · Karolinska Institutet · next primary completion Dec 2026
Reaching primary completion within a year · 3

Studies that test cabazitaxel.

Studies

Open first, then newest update. How each study uses cabazitaxel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 89

See all 89 studies that test cabazitaxel →

Given beside what is tested · 18 — cabazitaxel is usual care or a partner of the new treatment
As the comparator · 7 — what is tested is compared with cabazitaxel

Codes

What other systems call cabazitaxel · ClinicalTrials.gg INT005712

  • MeSH (NLM) C552428cabazitaxelConfirmed NLM, Wikidata
  • UNII (FDA) 51F690397JCABAZITAXELConfirmed FDA, NLM, Wikidata
  • RxNorm 996051Confirmed FDA, Wikidata
  • Wikidata Q412963cabazitaxelConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66937CabazitaxelOne source FDA
  • DrugBank DB06772One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.